Literature DB >> 19493430

Caspofungin in salvage treatment of severe pneumocystis pneumonia: case report and literature review.

Xiang-dong Mu1, Cheng-li Que, Bing He, Guang-fa Wang, Hai-chao Li.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19493430

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  8 in total

Review 1.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

2.  Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia.

Authors:  Gensheng Zhang; Miaomiao Chen; Shufang Zhang; Hongwei Zhou; Xiaozhen Ji; Jiachang Cai; Tianzheng Lou; Wei Cui; Ning Zhang
Journal:  Exp Ther Med       Date:  2017-11-16       Impact factor: 2.447

3.  Echinocandins for Pneumocystis jirovecii pneumonia in non-HIV patients: A case report.

Authors:  Hui-Bin Huang; Jing-Min Peng; Bin Du
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

4.  Management of Pneumocystis Jirovecii pneumonia in HIV infected patients: current options, challenges and future directions.

Authors:  Jose G Castro; Maya Morrison-Bryant
Journal:  HIV AIDS (Auckl)       Date:  2010-02-18

5.  Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia.

Authors:  Yingjiao Long; Cheng Zhang; Li Su; Chengli Que
Journal:  Exp Ther Med       Date:  2014-10-03       Impact factor: 2.447

6.  Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection.

Authors:  Q Tian; J Si; F Jiang; R Xu; B Wei; B Huang; Q Li; Z Jiang; T Zhao
Journal:  HIV Med       Date:  2020-12-04       Impact factor: 3.180

7.  Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin.

Authors:  Huan-Huan Wu; Shuang-Yan Fang; Yan-Xiao Chen; Lan-Fang Feng
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

8.  Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients.

Authors:  Xiang-Dong Mu; Peng Jia; Li Gao; Li Su; Cheng Zhang; Ren-Gui Wang; Guang-Fa Wang
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.